GLP-1 Receptor Agonists or SGLT2 Inhibitors and Nonarteritic Anterior Ischemic Optic Neuropathy
This cohort study evaluates the 3-year risk of nonarteritic anterior ischemic optic neuropathy among veterans with type 2 diabetes who initiated glucagon-like peptide-1 receptor agonists (GLP-1RAs) or a sodium-glucose cotransporter-2 (SGLT2) inhibitor.
Authors
- Taeyoung Choi
- Ziyad Al-Aly
- Yan Xie
Institutions
- Washington University in St. Louis (US)
- VA St. Louis Health Care System (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2026-04-30
- DOI
- https://doi.org/10.1001/jamanetworkopen.2026.9917
- Citations
- 1
- Primary Topic
- Intraoperative Neuromonitoring and Anesthetic Effects
- Type
- article
- Field-Weighted Citation Impact
- 24.54